-
First trimester screening for gestational diabetes mellitus by maternal factors and markers of inflammation.
Syngelaki A, Visser GH, Krithinakis K, Wright A, Nicolaides KH.
Metabolism 2016;65:131-7. pdf -
Longitudinal changes in maternal soluble endoglin and angiopoietin-2 in women at risk of preeclampsia.
Khalil A, Maiz N, Garcia-Mandujano R, ElKhouli M, Nicolaides KH.
Ultrasound Obstet Gynecol 2014;44:402-10. pdf -
Maternal serum visfatin at 11-13 weeks' gestation in preeclampsia.
Ferreira AF, Rezende JC, de Cassia C Oliveira R, Akolekar R, Nicolaides KH.
J Hum Hypertens 2013;27:261-4. -
Maternal serum visfatin at 11-13 Weeks of gestation in gestational diabetes mellitus.
Ferreira AF, Rezende JC, Vaikousi E, Akolekar R, Nicolaides KH.
Clin Chem 2011;57:609-13. -
Maternal serum angiopoietin-2 at 11 to 13 weeks of gestation in hypertensive disorders of pregnancy.
Akolekar R, Casagrandi D, Skyfta E, Ahmed AA, Nicolaides KH.
Prenat Diagn 2009;29:847-51.